March 25: EpiFrontier's $32M Grant; IMUNON's Phase 2 Data; More on Ocugen

VIEW IN BROWSER

Co-Producer

MARCH 25, 2026

Regional intelligence on Drugs, Diagnostics, Devices & Digital Health

* may need subscription to view

Press Releases

Join us April 2, 2026 for Now&Next – Meet the Leaders: ONCOLOGY.
This new series will launch with a focus on oncology and bring together life sciences executives, policymakers and patients to explore advances in key therapeutic areas.

Learn More →

CenTrak: Advances Its RTLS Platform Through Enhanced Healthcare Integrations More
IMUNON: Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival With IMNN-001 in Women With Newly Diagnosed Advanced Ovarian Cancer More
Otsuka: Showcases New Efficacy and Safety Data of VOYXACT (sibeprenlimab-szsi) in Patients With IgA Nephropathy (IgAN) at the 2026 ISN World Congress of Nephrology Highlighting the Impact of APRIL Inhibition More

Financial News

Investment Banking Advisory to the Life Science Industry

Learn More →

EpiFrontier Therapeutics: Secures up to $32M Grant From the Japan Agency for Medical Research and Development to Advance Novel Therapy for Beta Globin Disorders More
Large Pharma Companies Reduced Head Counts by More Than 22K in 2025 as $300B Patent Cliff Looms More
TELA Bio: Fourth Quarter and Full Year 2025 Financial Results More

Media/Misc Coverage

Pace® Life Sciences

The CDMO That Takes You Further. Your partner for Product Development, Manufacturing, Analytical Testing, Regulatory Consulting & Operational Support.

Learn More →

Modified Lipid Nanoparticles Boost mRNA Vaccine Delivery to Lymph Nodes More
More on Ocugen Eye Disease Gene Therapy Hitting Ph. 2 Targets But Underwhelms Investors More More*
Novo Nordisk Prepares to go Global as Triple-G Prospect Passes Midphase Diabetes Test in China More
Subscribe to LifeSci Startup for Updates on US Startups More

Career Center

Life Sciences Talent and Consulting Strategist George Quinn Named Partner, Fractional Talent at Slone Partners

Learn More →

AI in Biotech: The New Frontier for Leadership & Strategy More
11 Companies Hiring Clinical Professionals Now More
From Seed to Series C: What Investors Look for Beyond the Science More
Hiring Outlook: January Brings Year-Over-Year Layoff Decline More
ICYMI: CEO’s Perspective: Big Moves Come with Big Responsibility More
ICYMI: CEO’s Perspective: The High Cost of Job Hopping More
ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
Idorsia Looks for Another CEO — Again; Former Jazz Exec Makes a Comeback More*
M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
SJU: Path to Commercialization in Healthcare - Mady Hubbard & Jon Evoy Interview Alex Porion (Alkermes - Supply Chain) Podcast
The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More

Event Center

Note: Events may be in any Big4Bio region or virtual

CMO Summit 360°, April 13-14

Learn More →

Life Sciences Accounting & Reporting Congress 2026 March 23-25
Patients as Partners in Clinical Research March 24-26
Charles River Cell & Gene Therapy Summit March 26
CMO Summit 360° April 13-14
Drug Discovery Chemistry April 13-16
Life Science Innovation Northwest 2026 April 21-22
Delaware’s DNA | 2026 Life Science Conference April 30
Bio-IT World Conference & Expo May 19-21

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES

Big4Bio: Philadelphia Life Science Company Directory

Locate a specific company or explore new companies in life science.

Explore our Company Directory

Provided courtesy of

Philadelphia Sponsors

PREMIER

Spotlights Get Featured Company Directory News Contact Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe